These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27399311)

  • 21. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Travel Time to Colonoscopy Associated With Late-Stage Colorectal Cancer Among Medicare Beneficiaries in Iowa?
    Charlton ME; Matthews KA; Gaglioti A; Bay C; McDowell BD; Ward MM; Levy BT
    J Rural Health; 2016 Sep; 32(4):363-373. PubMed ID: 26610280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010.
    Lai SM; Jungk J; Garimella S
    Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
    Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
    Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
    Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the effectiveness of the Finnish population-based colorectal cancer screening programme.
    Chiu SY; Malila N; Yen AM; Chen SL; Fann JC; Hakama M
    J Med Screen; 2017 Dec; 24(4):182-188. PubMed ID: 28084889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcome of patients with screening versus symptomatically detected colorectal cancers.
    Pande R; Froggatt P; Baragwanath P; Harmston C
    Colorectal Dis; 2013 Jan; 15(1):74-9. PubMed ID: 22672571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved 5-year survival of patients with immunochemical faecal blood test-screen-detected colorectal cancer versus non-screening cancers in northern Italy.
    Parente F; Vailati C; Boemo C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Cereda D; Cremaschini M; Moretti R
    Dig Liver Dis; 2015 Jan; 47(1):68-72. PubMed ID: 25306524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
    Blom J; Törnberg S
    J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis.
    Mallinson EK; Newton KF; Bowen J; Lalloo F; Clancy T; Hill J; Evans DG
    Gut; 2010 Oct; 59(10):1378-82. PubMed ID: 20660077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.
    Panic N; Rösch T; Smolovic B; Radunovic M; Bulajic M; Pavlovic-Markovic A; Krivokapic Z; Djuranovic S; Ille T; Bulajic M
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1222-5. PubMed ID: 26067224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in patients with colorectal cancer diagnosed by screening colonoscopy.
    Friedrich K; Grüter L; Gotthardt D; Eisenbach C; Stremmel W; Scholl SG; Rex DK; Sieg A
    Gastrointest Endosc; 2015 Jul; 82(1):133-7. PubMed ID: 25986151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
    Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
    Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
    Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
    Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The NHS Bowel cancer screening programme achieves the anticipated survival improvement, but participation must be improved.
    Borowski DW; Cawkwell S; Zaidi SMA; Toward M; Maguire N; Garg DK; Gill TS
    Int J Health Care Qual Assur; 2018 Mar; 31(2):106-115. PubMed ID: 29504872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.